Not applicableUnknownNCT04862806What this trial is testingSafety, Efficacy of BNT162b2 mRNA Vaccine in CLLWho this might be right forChronic Lymphocytic Leukemia Bnai Zion Medical Center 1,000
Large-scale testing (Phase 3)Study completedNCT00145652What this trial is testingAdjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.Who this might be right forAnemiaMultiple MyelomaNon Hodgkin Lymphoma+1 more Sundsvall Hospital 66
Testing effectiveness (Phase 2)Study completedNCT01217749What this trial is testingEfficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLLWho this might be right forB-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaProlymphocyctic Leukemia+1 more Pharmacyclics LLC. 71
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Large-scale testing (Phase 3)Looking for participantsNCT05254743What this trial is testingPirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic LeukemiaLeukemia, LymphocyticLeukemia, B-cell+1 more Loxo Oncology, Inc. 737
Early research (Phase 1)Study completedNCT01534715What this trial is testingIMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaWho this might be right forLymphoma, Non-HodgkinChronic Lymphocytic Leukemia ImmunoGen, Inc. 49
Testing effectiveness (Phase 2)Ended earlyNCT01532635What this trial is testingA Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesWho this might be right forHematologic MalignancyLeukemiaAcute Lymphoblastic Leukemia+9 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4
Testing effectiveness (Phase 2)Study completedNCT00238433What this trial is testingBusulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaWho this might be right forLymphoma OHSU Knight Cancer Institute 37
Early research (Phase 1)Study completedNCT00348985What this trial is testingPXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more National Cancer Institute (NCI) 55
Early research (Phase 1)Study completedNCT00124189What this trial is testingSafety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)Who this might be right forChronic Lymphoproliferative Diseases Geron Corporation 48
Testing effectiveness (Phase 2)Study completedNCT02733042What this trial is testingDetermine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLymphomaLeukemia, Lymphocytic, Chronic, B-Cell Celgene 106
Testing effectiveness (Phase 2)UnknownNCT04059081What this trial is testingA Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based AssessmentWho this might be right forChronic Lymphocytic Leukemia Deok-Hwan Yang 31
Early research (Phase 1)Not Yet RecruitingNCT07679919What this trial is testingBAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic MalignanciesWho this might be right forNon-Hodgkin LymphomaChronic Lymphocytic LeukemiaHairy Cell Leukemia+1 more Luminary Therapeutics 27
Not applicableUnknownNCT03469895What this trial is testingAutoimmune Cytopenia and BcR InhibitorsWho this might be right forAutoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia Institut Paoli-Calmettes 40
Early research (Phase 1)Study completedNCT00004057What this trial is testingPaclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01532700What this trial is testingAn Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL) University Health Network, Toronto 28
Early research (Phase 1)Study completedNCT01653717What this trial is testingCD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)Who this might be right forAdvanced CancersLeukemia M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03960840What this trial is testingPhase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaDiffuse Large B-cell Lymphoma+2 more Novartis Pharmaceuticals 217
Early research (Phase 1)Active Not RecruitingNCT04732845What this trial is testingHuman AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia Benjamin Tomlinson 18
Not applicableUnknownNCT03971565What this trial is testingEvaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Assistance Publique Hopitaux De Marseille 47